家族性地中海熱の子供の栄養状態
Onur Bahçeci1, Fatma Aydın1, Zarife Kuloğlu2
1Department of Pediatrics, Division of Pediatric Rheumatology, Ankara University School of Medicine, Ankara, Turkey.
Postgraduate medicine
|August 22, 2025
まとめ
栄養不良は小児家族性地中海熱 (FMF) で一般的ですが,コルキシン治療で改善されます. 深刻な病気と初期栄養不良は FMF患者における持続的な問題の重要な要因です.
科学分野:
- 小児関節病学
- 栄養学
- 遺伝学
背景:
- 家族性地中海熱 (FMF) は遺伝的自己炎症性疾患である.
- 栄養状態は,小児のFMF管理でしばしば見過ごされます.
- 栄養不良や栄養過剰は 病気の進行や治療の有効性に 影響を及ぼします
研究 の 目的:
- FMFの小児患者における栄養不良 (栄養不良と栄養過剰) の有病率を決定する.
- コルキシン治療が栄養状態に与える影響を評価する.
- この集団における栄養失調に関連する要因を特定する.
主な方法:
- 532人の小児FMF患者の医療記録 (2011年−2024年) の遡及的レビュー.
- 患者の分類は正常,栄養不足,過剰栄養のグループに分類する.
- FMFの国際重症度評価システム (ISSF) を用いて病気の重度の評価
主要な成果:
- 栄養不良は診断時に32. 7%の患者で,コルキシン治療後に20. 7%に減少した.
- 栄養不足の有意な減少 (23. 5%から12. 8%) と栄養過剰の微妙な改善 (9. 2%から7. 9%) が観察されました.
- ISSFスコアが高くなったと,治療前と後の栄養失調が関連しており,重度の表型と初期栄養失調は持続的な栄養失調を予測した.
結論:
- 栄養不良は小児のFMFに多く見られるが,コルキシン治療に反応する.
- 栄養失調の早期発見と対処は 極めて重要です
- 疾患の重症度と初期栄養状態は,長期的なアウトカムを決定する重要な要因です.
関連する概念動画
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
419
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
419
Fungal Phylum Microsporidia
117
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
117
Overview of Protein Metabolism
1.8K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
1.8K
Inborn Errors of Metabolism
241
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
241
Chronic Kidney Disease II: Clinical Manifestations
87
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
87
Gastritis-II: Pathophysiology
543
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
543


